Capital Advisors Ltd’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3K Sell
40
-9
-18% -$592 ﹤0.01% 1050
2026
Q1
$3K Sell
49
-12
-20% -$946 ﹤0.01% 1036
2025
Q4
$5K Buy
61
+12
+24% +$935 ﹤0.01% 941
2025
Q3
$4K Sell
49
-5
-9% -$373 ﹤0.01% 955
2025
Q2
$4K Buy
54
+12
+29% +$835 ﹤0.01% 961
2025
Q1
$3K Hold
42
﹤0.01% 985
2024
Q4
$3K Sell
42
-6
-13% -$510 ﹤0.01% 1007
2024
Q3
$5K Buy
48
+6
+14% +$504 ﹤0.01% 916
2024
Q2
$3K Sell
42
-10
-19% -$816 ﹤0.01% 986
2024
Q1
$5K Buy
52
+8
+18% +$666 ﹤0.01% 878
2023
Q4
$3K Hold
44
﹤0.01% 938
2023
Q3
$3K Hold
44
﹤0.01% 930
2023
Q2
$4K Hold
44
﹤0.01% 883
2023
Q1
$4K Buy
+44
New +$3.14K ﹤0.01% 744

Other funds holding GEHC

Capital Advisors Ltd's GEHC Position: Q2 2026 in Review

Capital Advisors Ltd reduced its GE HealthCare (GEHC) stake by 18% in Q2 2026, selling an estimated $592 and leaving 40 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1050.

Capital Advisors Ltd first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $5K in Q4 2025. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Capital Advisors Ltd held 40 shares of GE HealthCare worth $3K as of Q2 2026.
  • Capital Advisors Ltd sold 9 GE HealthCare shares in Q2 2026, an estimated $592.
  • GE HealthCare made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1050 holding.
  • Capital Advisors Ltd first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Capital Advisors Ltd's GE HealthCare position peaked at $5K in Q4 2025.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.